Quick Search

 

 


 

 

Result Summary for 111712

Result Summary
Protocol ID: 111712
Clinical Study ID: 111712
Official Title: Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK-580299) in healthy female subjects.
Phase: phase 3
Study Indications or Diseases:
  • Infections, Papillomavirus
Generic Name: Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name: Cervarix
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.